<DOC>
	<DOC>NCT00405080</DOC>
	<brief_summary>This study will examine what the body does while taking GW679769 alone and together with rifampin in healthy adult subjects.</brief_summary>
	<brief_title>A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Casopitant</mesh_term>
	<criteria>Inclusion criteria: healthy female subjects who cannot become pregnant able to swallow and keep down oral medication can understand and follow the protocol requirements and instructions Exclusion criteria: smokes at least 4 packs per day in the past 12 months use of prescription or nonprescription drug(s) herbal or dietary supplements or vitamins with 14 days prior to first dose of study medication a clinically relevant abnormality medical condition or circumstance making the subject unsuitable for the study per the study doctor blood donation in excess of 1 pint within 56 days before dosing of medication iron deficient history or drug allergy of study medication history of drug or alcohol abuse or dependency within the past 6 months subjects cannot use any nicotinecontaining products within the last 6 months positive for HIV, Hepatitis B or C active peptic ulcer disease uncontrolled nausea and vomiting active infection heart failure female who is lactating female who has a positive pregnancy test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Rifampin GW679769</keyword>
</DOC>